1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources

Resources

151 - 165 of 167 Results
Sort Results:
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Commentary: Restricted Use of Rosiglitazone-Containing Products October 2010
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Chart: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (AACE) October 2010
Patient Education: Avandia and Risk of Heart Attack August 2010
Other: See new FDA information concerning the restricted use of Avandia August 2010
Guideline: Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes (ADA, 2009) August 2010
Guideline: Aspirin for Primary Prevention of Cardiovascular Events in People with Diabetes (2010) July 2010
Commentary: Aspirin for Primary Prevention in Patients with Diabetes July 2010
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) May 2010
Guideline: AACE Diabetes Management Consensus Statement (2013). May 2010
Other: Senate Concerns about Avandia April 2010
Commentary: Avandia and Cardiovascular Safety: Ongoing Review April 2010
Commentary: Insulins March 2010
Commentary: New Drug: Victoza (Liraglutide) March 2010